Summary and conclusion - Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management.
27 August 2017 (13:40 - 13:45)
Organised by:
About the speaker
Saarland University Hospital, Homburg (Germany)
4 More presentations in this session
Professor M. Weir (Baltimore, US)
Access the full session
The Event
ESC Congress 2017
27 August 2017
13:40 CET
You may be interested in
Congress Presentation
Congress Presentation
1 September 2019
